© Reuters. FILE PHOTO: GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File Photo
(Reuters) – British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon, cutting its shareholding to 4.2% in the world’s largest standalone consumer healthcare firm.
GSK sold around 300 million shares in its spun-off unit at a price of 326 pence per share.
($1 = 0.7918 pounds)
By Surbhi Misra (Reuters) - The Chinese language-linked Salt Storm cyberespionage operation focused AT&T (NYSE:)'s programs, however the wi-fi provider's...
This text was written byComply withInvesting in European, Asian and American shares since 2013 with concentrate on worth, progress at...
LONDON (Reuters) - British Prime Minister Keir Starmer has requested the nation's regulators, together with the monetary and competitors watchdogs,...
Investing.com -- Citi analysts have unveiled their Q1 2025 fairness technique, emphasizing a extra balanced method amid evolving macroeconomic situations...
Investing.com -- It has been an especially gradual week in relation to markets, however we now have managed to seek out...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
